Reporte de Automatización con IA para Probiomed

Probiomed is a leading Mexican biopharmaceutical company that specializes in the research, development, and manufacturing of high-tech medicines, particularly biosimilars and recombinant proteins. The company operates state-of-the-art production facilities and focuses on chronic-degenerative diseases such as cancer, rheumatoid arthritis, and chronic kidney disease. Their primary business model involves large-scale manufacturing and high-volume B2G (Government) and B2B (Private Hospitals) sales within Mexico and internationally. As one of the few national companies with the capacity for complete biotechnological development, Probiomed is a key player in Mexico's public health system and pharmaceutical industry.